BackPetros Pharmaceuticals Overview

Petros Pharmaceuticals Current Cash

Track Petros Pharmaceuticals's current cash ($4.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$4.35M
51.27% YoYΔ $-4.58M vs prior year quarter

Peer average

Loading

Petros Pharmaceuticals Current Cash History

Loading

Petros Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Petros Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Petros Pharmaceuticals (PTPI) FAQ

The latest current cash for PTPI is $4.4M as of March 2026. That compares with $8.9M in the prior-year period — down 51.3% year over year. Investors often review this figure alongside Petros Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, PTPI's current cash moved from $8.9M to $4.4M — a 51.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Petros Pharmaceuticals's operating scale or balance-sheet position.

A current cash figure of $4.4M for PTPI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PTPI's current cash ($4.4M), review year-over-year change from $8.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Petros Pharmaceuticals's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.